Immunization mice antibiotic-treated Escherichia coli results enhanced protection challenge homologous heterologous bacteria murine immune response Escherichia coli subminimal inhibitory concentrations antibiotics Groups mice weeks formalin-killed bacteria viable coli Mice saline controls mortality mice ciprofloxacin-treated coli mice coli antibiotics Sera mice ciprofloxacin-treated bacteria bacteriostatic capacity enhanced production antibodies homologous heterologous several smooth rough gram-negative strains protection mice ciprofloxacin-treated coli due enhanced production antibodies lipopolysaccharide accessible treatment ciprofloxacin 